18 Mar, 2022 10:23 AM
* AstraZeneca extends its second contract for a Phase IIb trial, which is utilising SOZO® to measure fluid volume in patients with chronic kidney disease, by 3 months.
* In ad...read more
11 Feb, 2022 08:49 AM
ImpediMed Limited (ASX.IPD) is pleased to announce it has entered into an agreement with balboa RESEARCH SMO+ (“Balboa”) and Frenova Renal Research, a Fresenius Medical Care Company, to ...read more
01 Feb, 2022 08:24 AM
ImpediMed Limited (ASX.IPD) is pleased to announce the PREVENT Trial results have been peer-reviewed and published in Lymphatic Research and Biology, a journal dedicated to research on lymphatic bio...read more
18 Nov, 2021 08:23 AM
ImpediMed Limited (ImpediMed or the Company) (ASX:IPD) is pleased to announce the successful completion of its Share Purchase Plan (SPP). The SPP closed on Thursday, 12 November 2021 heavily oversub...read more
10 Nov, 2021 10:41 AM
Set out below are the results of the 2021 Annual General Meeting (AGM) held earlier today. All resolutions put to the AGM were decided by a poll.
For more information, download the attached PDF.
10 Nov, 2021 08:33 AM
So welcome and thank you for joining us today. I hope that all of you and your families are healthy and are continuing to successfully navigate this pandemic.
As I begin my prepared remarks, I wo...read more
04 Nov, 2021 11:52 AM
AstraZeneca extends its contract for the Phase IIb trial, which is utilising SOZO® to measure fluid volume in patients with heart failure and chronic kidney disease, by 3 mont...read more
03 Nov, 2021 12:03 PM
You should read this Booklet in full. Eligible Shareholders have the opportunity to participate in the Share Purchase Plan offer by applying for up to $30,000 of new Shares without incurring brokera...read more
03 Nov, 2021 12:02 PM
The Share Purchase Plan (SPP) announced by ImpediMed Limited (ImpediMed or the Company) (ASX: IPD) on Wednesday, 27 October 2021 opens today. Eligible Shareholders in Australia and New Zealand now h...read more